All Insights
A shot in the arm for generics as UK courts refuse injunction to prevent potential patent infringement
In an unusual decision for life sciences patent disputes, the UK courts refused to restrain a generic drug manufacturer from
A unified patent court for Europe: the coup de grâce?
Will we ever see the Unified Patent Court operate? Many have doubts, as its path – already long and difficult
UK Supreme Court upholds appeal by biotech firm Kymab to revoke antibody patents held by US giant Regeneron
Judgment overturns the Court of Appeal's decision on ground-breaking technology, rebalances the legal equilibrium on sufficiency, and grants reprieve to
SkyKick: High Court narrows Sky's trade mark protection and criticises the use of trade marks as a weapon
What are the implications for brand owners?
CJEU clarifies conditions for obtaining SPC protection for medicinal products
Royalty Pharma: the CJEU's latest decision on Supplementary Protection Certificates addresses when medicinal products can be "protected by a basic
Data protection and Covid-19: French companies, their suppliers and contractors, and cyber risks
As lockdown is extended in France for a few more weeks, companies still need to ensure they adopt actions required
Coronavirus Legal Briefing | The EU's exit strategy for business
Welcome to Osborne Clarke's Coronavirus Legal Briefing, our newsletter on business law issues in these sombre times.
Coronavirus Legal Briefing | What we're seeing
Welcome to Osborne Clarke's Coronavirus Legal Briefing, our newsletter on business law issues in these sombre times.
Coronavirus A guide for your business
COVID-19 – and the measures governments have implemented to slow the spread of the virus – represent an unprecedented challenge
